These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23116265)

  • 1. C-Jun terminal kinases play an important role in regulating embryonic survival and eye development in vertebrates.
    Huang XQ; Huang ZX; Li ZL; Chen XW; Li X; Tang XC; Liu FY; Liu Y; Chen L; Han WJ; Liu L; Li L; Wu KL; Wu MX; Liu XL; Luo LX; Yu MB; Liu YZ; Liu SJ; Li DW
    Curr Mol Med; 2013 Jan; 13(1):228-37. PubMed ID: 23116265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK signaling pathway regulates embryonic survival and eye development in goldfish, Carassius auratus.
    Li L; Wang L; Li TT; Li X; Huang XQ; Chen XW; Li ZL; Lv XM; Liu FY; Luo ZW; Liu M; Hu XH; Hu WF; Huang ZX; Yi M; Liu SJ; Liu YZ; Li DW
    Curr Mol Med; 2013 Jul; 13(6):959-67. PubMed ID: 23745584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration.
    Barnat M; Enslen H; Propst F; Davis RJ; Soares S; Nothias F
    J Neurosci; 2010 Jun; 30(23):7804-16. PubMed ID: 20534829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Jun N-terminal kinase 1 (JNK1) is required for coordination of netrin signaling in axon guidance.
    Qu C; Li W; Shao Q; Dwyer T; Huang H; Yang T; Liu G
    J Biol Chem; 2013 Jan; 288(3):1883-95. PubMed ID: 23223444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases.
    Chen J; Ye C; Wan C; Li G; Peng L; Peng Y; Fang R
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
    Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
    Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
    Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
    Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain JNK and metabolic disease.
    Nogueiras R; Sabio G
    Diabetologia; 2021 Feb; 64(2):265-274. PubMed ID: 33200240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-jun promoter activation and NGF withdrawal-induced death.
    Eilers A; Whitfield J; Shah B; Spadoni C; Desmond H; Ham J
    J Neurochem; 2001 Mar; 76(5):1439-54. PubMed ID: 11238729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer.
    Choi HS; Bode AM; Shim JH; Lee SY; Dong Z
    Mol Cell Biol; 2009 Apr; 29(8):2168-80. PubMed ID: 19204086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
    Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
    Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo.
    Kaiser RA; Liang Q; Bueno O; Huang Y; Lackey T; Klevitsky R; Hewett TE; Molkentin JD
    J Biol Chem; 2005 Sep; 280(38):32602-8. PubMed ID: 16043490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1.
    Lu W; Liu Y; Gao Y; Geng Q; Gurbani D; Li L; Ficarro SB; Meyer CJ; Sinha D; You I; Tse J; He Z; Ji W; Che J; Kim AY; Yu T; Wen K; Anderson KC; Marto JA; Westover KD; Zhang T; Gray NS
    J Med Chem; 2023 Mar; 66(5):3356-3371. PubMed ID: 36826833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signaling.
    Abdelli S; Bonny C
    PLoS One; 2012; 7(5):e35997. PubMed ID: 22563476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin stimulates activation of c-jun N-terminal kinase (JNK).
    Schwertfeger KL; Hunter S; Heasley LE; Levresse V; Leon RP; DeGregori J; Anderson SM
    Mol Endocrinol; 2000 Oct; 14(10):1592-602. PubMed ID: 11043575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
    Katagiri C; Negishi K; Hibino T
    J Dermatol Sci; 2006 Sep; 43(3):171-9. PubMed ID: 16824735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All JNKs can kill, but nuclear localization is critical for neuronal death.
    Björkblom B; Vainio JC; Hongisto V; Herdegen T; Courtney MJ; Coffey ET
    J Biol Chem; 2008 Jul; 283(28):19704-13. PubMed ID: 18474608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1).
    Kaur S; Wang F; Venkatraman M; Arsura M
    J Biol Chem; 2005 Nov; 280(46):38599-608. PubMed ID: 16157589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms.
    de Lemos L; Junyent F; Camins A; Castro-Torres RD; Folch J; Olloquequi J; Beas-Zarate C; Verdaguer E; Auladell C
    Mol Neurobiol; 2018 May; 55(5):4437-4452. PubMed ID: 28664455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.
    Vivo C; Liu W; Broaddus VC
    J Biol Chem; 2003 Jul; 278(28):25461-7. PubMed ID: 12707267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.